Local 12: Marijuana use and testicular cancer
UC urologist comments on research surrounding the use of marijuana and the tie to testicular cancer
As marijuana becomes legal in many states for medical and recreational use, researchers are beginning to learn more about its potential benefits and risks.
Via a review article in JAMA Network Open, researchers concluded that there was not enough evidence linking marijuana to lung, head and neck or oral cancers. But they did find a possible link to smoking marijuana and testicular cancer.
"There was a slightly higher risk of testicular cancer in patients who were marijuana smokers for more than 10 years," said Dr. Abhinav Sidana, assistant professor of surgery at the University of Cincinnati and director of urologic oncology with UC Health.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.